CLINICAL_TRIALS
trial_result
· 2025-07-30
Clinical Trial Update: Intravitreal Faricimab in Patients With Refractory Macular Edema [Phase 2]
Summary
Phase 2 trial update evaluating intravitreal faricimab for refractory macular edema in age-related macular degeneration.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Baghdad | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED